NeuroMetrix, Inc. financial data

Symbol
NURO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1000 Winter Street, Waltham, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.35K % -19.1%
Quick Ratio 104 % -4.02%
Debt-to-equity 8.21 % +14.8%
Return On Equity -41.7 % -71.2%
Return On Assets -38.6 % -69.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.03M shares -76.4%
Common Stock, Shares, Outstanding 2.02M shares -76.5%
Entity Public Float 8.18M USD -68.4%
Common Stock, Value, Issued 202 USD -76.5%
Weighted Average Number of Shares Outstanding, Basic 2M shares +103%
Weighted Average Number of Shares Outstanding, Diluted 2M shares +103%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 1.74M USD -26.5%
Research and Development Expense 2.54M USD -17.3%
Selling and Marketing Expense 3.3M USD +10%
General and Administrative Expense 5.7M USD +22.4%
Operating Income (Loss) -8.9M USD -50.8%
Nonoperating Income (Expense) 341K USD +294%
Net Income (Loss) Attributable to Parent -7.94M USD -46.7%
Earnings Per Share, Basic -5.48 USD/shares +30.3%
Earnings Per Share, Diluted -5.48 USD/shares +30.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.61M USD -13.7%
Cash, Cash Equivalents, and Short-term Investments 16.4M USD -16.3%
Accounts Receivable, after Allowance for Credit Loss, Current 281K USD -62.4%
Inventory, Net 1.45M USD -8.43%
Assets, Current 18.5M USD -17.1%
Property, Plant and Equipment, Net 244K USD +67.8%
Operating Lease, Right-of-Use Asset 183K USD -41.4%
Other Assets, Noncurrent 26.4K USD 0%
Assets 18.9M USD -16.9%
Accounts Payable, Current 314K USD +73%
Accrued Liabilities, Current 1.13M USD +28.1%
Liabilities, Current 1.59M USD +31.4%
Operating Lease, Liability, Noncurrent 28.2K USD -81.5%
Liabilities 1.62M USD +18.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 112K USD -33.5%
Retained Earnings (Accumulated Deficit) -215M USD -3.84%
Stockholders' Equity Attributable to Parent 17.3M USD -19.1%
Liabilities and Equity 18.9M USD -16.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.08M USD -85.6%
Net Cash Provided by (Used in) Financing Activities 1.47M USD
Net Cash Provided by (Used in) Investing Activities 138K USD
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 2.02M shares -76.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -472K USD +75.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.61M USD -13.7%
Deferred Tax Assets, Valuation Allowance 6.42M USD +31.8%
Deferred Tax Assets, Gross 6.48M USD +30.2%
Depreciation 10.2K USD -20.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.99M USD -52.5%
Lessee, Operating Lease, Liability, to be Paid 200K USD -45.3%
Property, Plant and Equipment, Gross 1.03M USD +21.7%
Operating Lease, Liability, Current 148K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 117K USD -29.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 117K USD -29.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 117K USD -29.2%
Deferred Tax Assets, Operating Loss Carryforwards 4.29M USD +27.3%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 117K USD -29.2%
Additional Paid in Capital 232M USD +1.71%
Depreciation, Depletion and Amortization 24.9K USD +144%
Deferred Tax Assets, Net of Valuation Allowance 0 USD